<bill session="107" type="hc" number="126" updated="2013-07-14T18:58:57-04:00">
  <state datetime="2001-05-03">REFERRED</state>
  <status>
    <introduced datetime="2001-05-03"/>
  </status>
  <introduced datetime="2001-05-03"/>
  <titles>
    <title as="introduced" type="official">Expressing the sense of the Congress that the United States Trade Representative should investigate whether any price control program governing the cost of medication in Mexico or Canada violates any trade agreement.</title>
  </titles>
  <sponsor id="400116"/>
  <cosponsors/>
  <actions>
    <action datetime="2001-05-02">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E704"/>
    </action>
    <action state="REFERRED" datetime="2001-05-03">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
    <action datetime="2001-05-08">
      <text>Referred to the Subcommittee on Trade.</text>
      <committee name="House Committee on Ways and Means"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM04" subcommittee="Trade" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Canada"/>
    <term name="Commerce"/>
    <term name="Economics and public finance"/>
    <term name="Governmental investigations"/>
    <term name="Health"/>
    <term name="International affairs"/>
    <term name="Latin America"/>
    <term name="Mexico"/>
    <term name="Prescription pricing"/>
    <term name="Price regulation"/>
    <term name="Trade agreements"/>
  </subjects>
  <amendments/>
  <summary>5/3/2001--Introduced.
Expresses the sense of Congress that the United States Trade Representative should investigate whether any price control program governing the cost of medication in Mexico or Canada violates any trade agreement (or otherwise denies benefits to the United States under any trade agreement), or is discriminatory and burdens or restricts U.S. commerce.</summary>
</bill>
